戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 re indicating clear or almost clear plus a 2-grade improvement in the IGA score for the intertriginou
2 ase activity thanks to a semi-quantitative 4-grade scale, named respectively PGA (Physician Global As
3                                          All-grade infusion reactions were less frequent with acalabr
4 rade IDH differentiation syndrome (17%), all-grade electrocardiogram QT prolongation (26%), and grade
5 , hyperphosphataemia was the most common all-grade adverse event irrespective of cause (88 [60%] of 1
6                          The most common all-grade adverse events were diarrhea (n = 18; 53%), fatigu
7  group had a significantly high risk for all-grade immune-related adverse events.
8 erse events of special interest included all-grade IDH differentiation syndrome (17%), all-grade elec
9 robaileyales together form the so-called ANA-grade of angiosperms, which are extant representatives o
10                                          Any-grade treatment-related adverse events occurred in 18 pa
11 ion mechanisms in polycrystalline biomedical-grade superelastic NiTi are spatially mapped using in si
12                                     Clinical-grade rigosertib, which is free of this impurity, does n
13 cking the RSPO3-LGR4 interaction by clinical-grade anti-RSPO3 antibody (OMP-131R10/rosmantuzumab) imp
14 e and relevant quality controls for clinical-grade hiPSCs remain imperative.
15 eatly increase capacity to generate clinical-grade peptides on demand, which is a key step in reachin
16 ect manager to facilitate obtaining clinical-grade biomarkers (blood/tissue NGS, specific immunohisto
17 w have been guided by biomarkers or clinical-grade assays developed to predict patient response and,
18 lockade of the NRG1/HER3 axis using clinical-grade blocking antibodies re-sensitizes tumors to hormon
19 The methodology was validated using clinical-grade induced pluripotent stem cell-derived retinal pigm
20  weight that it may be flown on a commercial-grade UAV.
21 rations currently measured on two commercial-grade cell-free tumour DNA platforms, despite the use of
22                                     Consumer-grade game controllers have emerged as a viable means to
23 by conducting aerial surveys with a consumer-grade quadcopter (DJI Phantom 3), while concurrently rec
24  modules for a unified outcome of diagnostic-grade reliability: A 4-minute, parent-report questionnai
25                    Cancer detection, disease-grade changes, and cancers missed at in-bore MRI-guided
26  study included 5,193 kindergarten and first-grade students enrolled from 13 communities in 2002-2003
27 erolysis of propyl gallate (PG) using a food-grade lipase (Lipozyme(R) 435).
28 ent study developed novel highly active food-grade antimicrobial peptides affecting a wide range of b
29  immobilized and commercially available food-grade Candida antarctica lipase B, Lipozyme(R) 435, was
30 nd bromelain were selected out of eight food-grade enzymes for the kinetic analysis of peanut protein
31 Cs) and lauric arginate (LAE), which is food-grade cationic surfactant.
32                   This study shows that food-grade Pickering emulsions with good stability can be pro
33                                         High-grade (grades 3-5) injuries were less likely to resolve
34                                         High-grade gliomas (HGG) afflict both children and adults and
35                                         High-grade nonmuscle invasive bladder cancer (HRNMIBC) is a h
36                                         High-grade serous carcinoma (HGSC), an epithelial cancer phen
37                                         High-grade serous carcinoma, accounts for up to 70% of all ov
38                                         High-grade serous ovarian cancer patient tumors and cells exp
39                                         High-grade serous ovarian cancers show increased replication
40                                         High-grade serous ovarian carcinoma (HGSC), the most common s
41                                         High-grade serous ovarian carcinoma (HGSOC) is the most letha
42                                         High-grade serous ovarian carcinoma (HGSOC) is the most letha
43                                         High-grade serous ovarian carcinoma is characterised by TP53
44                                         High-grade T1 (HGT1) bladder cancer is the highest risk subty
45 ith 4.7% (95% CI, 2.5%-8.5%; I(2) = 0%) high-grade squamous intraepithelial lesions.
46 >=3 s electrical pause or asystole; (2) high-grade Mobitz type II atrioventricular block or complete
47 grade glioma (n = 93), ependymoma (32), high-grade glioma (25), medulloblastoma (22), ganglioglioma (
48  with cerebral gliomas (9 low-grade, 34 high-grade; 9 primary tumors, 34 recurrent tumors) who had pr
49 consistent and reproducible growth of a high-grade glioma in all animals.
50 nt study, we report the production of a high-grade spinal cord glioma model in pigs using lentiviral
51 th carcinoma in situ (with or without a high-grade Ta or T1 tumour) had a complete response within 3
52 th carcinoma in situ (with or without a high-grade Ta or T1 tumour).
53 or advanced colorectal neoplasia (aCRN, high-grade dysplasia, or CRC) in patients with IBD.
54 p developed response criteria for adult high-grade glioma, but these were not created to meet the uni
55 mmendations for the management of adult high-grade glioma, for paediatrics there is inclusion of diff
56                     Pediatric and adult high-grade gliomas (HGGs) frequently harbor PDGFRA alteration
57 quently develops in women with advanced high-grade serous ovarian cancer (HGSOC) and is associated wi
58 fectiveness of qHPV vaccination against high-grade cervical precancerous lesions, among women vaccina
59 le sub-network that is perturbed in all high-grade tumor regions.
60 lomavirus-16 incidence was higher among high-grade versus no lesion at baseline (adjusted incidence r
61 sis were conducted with histologic anal high-grade squamous intraepithelial lesion (A-HSIL) as the de
62                                    Anal high-grade squamous intraepithelial lesions (HSILs) precede a
63 uman papillomavirus (HPV) genotypes-and high-grade anal intraepithelial neoplasia (HGAIN) in men who
64 t can also efficiently bind B cells and high-grade B cell lymphoma (diffuse large B cell lymphoma) ce
65 R 4.53, 95%CI 1.34-15.26; P = 0.02) and high-grade dysplasia (HGD) in the original resection (HR 3.60
66 nomas, adenomas >=20 mm in diameter and high-grade dysplasia were associated with increased risk of c
67 isk factors such has family history and high-grade dysplasia.
68 static cancers, including low-grade and high-grade gliomas and brain metastases (BrMs) originating fr
69 n distinction between the low-grade and high-grade intraepithelial melanocytic proliferations and nee
70 Family history of pancreatic cancer and high-grade IPMN was identified as risk factors for recurrence
71 ent in distinction between the low- and high-grade lesions was 76% for PAM, 67% for conjunctival mela
72 ritability (h(g)(2)) of EOC overall and high-grade serous ovarian cancer (HGSOCs) were estimated to b
73 anastomosis, in the trunk (critical and high-grade), or in both sections.
74 e percentage of (Gleason pattern-based) high-grade cancers (PHG) is demonstrated in EAs (p < 0.01) bu
75 udy Group database with primary central high-grade osteosarcoma of the extremities, treated between 1
76 gnosis of patients with primary central high-grade osteosarcoma of the extremities.
77 rmediate (non-metastatic R0 or R1 >5 cm high-grade, or unresected tumour of any size or grade); or hi
78  The association between CAC and 90-day high-grade CAD and revascularization were assessed.
79 tection rate of 100% (8/8) in detecting high-grade dysplasias and carcinomas over white-light detecti
80  age-matched Pten littermates developed high-grade prostatic intraepithelial neoplasia and prostate c
81 y (PET/CT), is often used to assess for high-grade coronary artery disease (CAD) requiring revascular
82       Clinical trials of treatments for high-grade gliomas have traditionally relied on measures of r
83 urrent trials and clinical practice for high-grade gliomas.
84 erentiate low-grade (Fuhrman I-II) from high-grade (Fuhrman III-IV) renal cell carcinoma using radiom
85 -P could further be differentiated from high-grade prostatic intraepithelial neoplasia (HGPIN), a pre
86 3b(K27M) and Pik3ca(H1047R) to generate high-grade diffuse gliomas.
87  1.09 (95% CI, 0.85-1.33) for low-grade/high-grade dysplasia and 0.14 (95% CI, 0.06-0.22) for GC.
88 rates of lesions suspected of harboring high-grade dysplasia or early adenocarcinoma, a novel grasp a
89 phy (3.4% versus 10.2%, P<0.0001), have high-grade CAD (0.5% versus 6.5%, P<0.0001), and receive reva
90 tifies PET/CT patients unlikely to have high-grade CAD or require revascularization within 90 days an
91 functionally silenced, HR+, CARM1-high, high-grade serous ovarian cancer cells become PARPi sensitive
92  in well characterized cohorts of human high-grade astrocytomas, mostly glioblastomas, compared to he
93 nd Obstetrics (FIGO; 1988) stage IC-IIA high-grade serous, clear cell, or any poorly differentiated o
94                                      In high-grade B-cell lymphoma, angiogenesis correlates with poor
95 ssion from treatment-related changes in high-grade glioma patients.
96 ession and treatment-related changes in high-grade glioma patients.
97 s associated with favourable outcome in high-grade glioma.
98 C showed significantly higher levels in high-grade lesions.
99 mmaH2AX-TAT localizes preferentially in high-grade PanIN lesions but not in established PDAC.
100 , gammaH2AX expression was increased in high-grade PanINs but not in PDAC, corroborating earlier resu
101  SOX9 is significantly overexpressed in high-grade PC tumors (P < 0.05) and in chemotherapy-treated p
102 , P<0.001) were significantly higher in high-grade segments.
103 tein convertase, is highly expressed in high-grade serous carcinoma of ovarian cancer patients, and i
104 ring neoadjuvant chemotherapy (NACT) in high-grade serous ovarian cancer (HGSOC), we performed immuno
105  (CRISPR)-mediated knockout of FABP4 in high-grade serous ovarian cancer cells reduced metastatic tum
106                                      In high-grade serous ovarian cancer, Galgo signatures obtained s
107 perior efficacy to gemcitabine alone in high-grade serous ovarian cancer.
108 ated with better survival (p = 0.01) in high-grade serous.
109 ed 18 years and older with stage III/IV high-grade serous, endometrioid, or clear cell ovarian cancer
110 included diffuse large B-cell lymphoma, high-grade B-cell lymphoma with rearrangements of MYC and eit
111                                    Many high-grade serous carcinomas (HGSCs) likely originate in the
112  is an emerging precursor to neoplastic high-grade B-cell lymphoproliferation among people with HIV,
113 Apc(min) mice with increased numbers of high-grade adenomas.
114 ty tables that include the incidence of high-grade adverse events, defined by the Common Terminology
115 S); 20 LBCL-IRF4 cases; and 12 cases of high-grade B-cell lymphoma (HGBCL), NOS in patients <=25 year
116  three years between the development of high-grade dysplasia and pancreatic cancer.
117 sion of advanced adenomas, diagnosis of high-grade dysplasia in the rectum or pouch, or progression o
118 p53 pathways to induce the formation of high-grade gliomas in rodent models.
119 tracers for the treatment evaluation of high-grade gliomas.
120 ce correlates with a prior detection of high-grade lesions.
121 odel, the parameters most predictive of high-grade melanocytic intraepithelial lesion/melanoma in sit
122 reatic cancer involves visualization of high-grade pancreatic intraepithelial neoplasias (PanIN-3s),
123 ce, which correlated with the number of high-grade PanINs.
124  3, 6, and 9 was done in the absence of high-grade recurrence.
125 cells derived from malignant ascites of high-grade serous adenocarcinoma patients.
126 e prevailing paradigm in the genesis of high-grade serous carcinoma (HGSC), the most common ovarian c
127 n glycosylation in the heterogeneity of high-grade serous ovarian carcinoma (HGSC), we perform mass s
128 ve identified transcriptome subtypes of high-grade serous ovarian carcinoma (HGSOC), but their interp
129  lentiviral vector induced pig model of high-grade spinal cord glioma and may potentially be used in
130 ium 68 DOTATATE PET/CT, and in cases of high-grade tumors, they were also evaluated with fluorine 18
131  virus (HIV) plasma viral load (PVL) on high-grade cervical intraepithelial neoplasia (CIN2+) detecti
132 cation based on adenoma size >=20 mm or high-grade dysplasia (instead of the current high-risk classi
133 (<1cm, and without villous histology or high-grade dysplasia) and no neoplasia, respectively (log-ran
134 0mm, adenomas with villous histology or high-grade dysplasia, or colorectal cancer [CRC]) and assesse
135 ascular invasion, hydronephrosis and/or high-grade upper tract disease(3-5).
136    Robust preclinical models of ovarian high-grade serous carcinoma (HGSC) are needed to advance our
137 sely mirror those of human tubo-ovarian high-grade serous carcinoma.
138        Response criteria for paediatric high-grade glioma vary historically and across different coop
139 onse assessment criteria for paediatric high-grade glioma.
140 in assessing the response of paediatric high-grade gliomas to various treatments.
141 ny adenoma with villous growth pattern, high-grade dysplasia, or >=10 mm in diameter).
142 rhabdoid tumors (n = 229) and pediatric high-grade gliomas (n = 401), we show significant association
143 pients receiving valganciclovir as PET, high-grade HHV-6 viremia was associated with increased age an
144 psy revealed a cytokeratin 20-positive, high-grade neuroendocrine neoplasm consistent with Merkel cel
145                           Posttreatment high-grade gliomas are usually monitored with contrast-enhanc
146          Tumors displayed predominantly high-grade morphology with abundant granular eosinophilic cyt
147 , Frmd6/Pten double knockouts presented high-grade prostatic intraepithelial neoplasia (HG-PIN) and h
148 illomavirus (HPV) vaccine in preventing high-grade cervical lesions have been shown.
149 ty in CO(2) hydrogenation and producing high-grade methanol.
150 static R0 or R1 low-grade, or <=5 cm R1 high-grade tumour); intermediate (non-metastatic R0 or R1 >5
151  the tumor region, CMRO(2) was reduced (high-grade tumor CMRO(2), 0.23 mumol/g/min +/- 0.07; low-grad
152 ars) with recurrent, platinum-resistant high-grade serous ovarian cancer (determined histologically)
153 ib to gemcitabine in platinum-resistant high-grade serous ovarian cancer.
154 rs or older who had platinum-sensitive, high-grade serous or endometrioid ovarian, primary peritoneal
155 ade ACLF in terms of risk of subsequent high-grade ACLF are unclear.
156 the following five histologic subtypes: high-grade myxoid liposarcoma (HG-MLPS); leiomyosarcoma (LMS)
157 of the low-grade cancers and 71% of the high-grade cancers according to the consensus reading.
158                           Tumors of the high-grade serous carcinoma (HGSC) type represent the most co
159  with low-grade disease may progress to high-grade disease after immune modulation, which can be effe
160 atients at high risk for progression to high-grade dysplasia (HGD) or EAC are needed to improve outco
161 ntraepithelial lesion from low-grade to high-grade in 2 (4%) of 47 cases.
162 at baseline, the risk of progression to high-grade SILs (HSILs) and the clearance rate were estimated
163 r continental crust may be strong under high-grade conditions.
164 atment with interferon-alpha2b, whereas high-grade disease requires immunochemotherapy.
165 vated Notch activity is associated with high-grade disease and metastasis.
166 mune surveillance of EBV, patients with high-grade disease may have a recurrence in the form of low-g
167 current colonic adenoma associated with high-grade dysplasia (HGD) colon polyps at baseline colonosco
168 BE samples collected from patients with high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC)
169 ion (ER) and ablation for patients with high-grade dysplasia (HGD) or intramucosal adenocarcinoma (IM
170 referred treatment for BE patients with high-grade dysplasia (HGD).
171 o [SIR] 2.07; 95% CI 1.40-2.93) or with high-grade dysplasia (SIR 0.79; 95% CI 0.39-1.41), whereas fo
172 on in plasma EV of the 11 patients with high-grade dysplasia alone, only 1 had high MUC5AC expression
173 uctal papillary mucinous neoplasms with high-grade dysplasia and some enlarged pancreatic intraepithe
174 atures was associated (P = 0.0002) with high-grade ICANS.
175        Studies have documented AKI with high-grade proteinuria in patients with severe acute respirat
176 -line, platinum-based chemotherapy with high-grade serous or endometrioid EOC should be offered PARPi
177 029) were significantly associated with high-grade viremia.
178 val among children and adolescents with high-grade, high-risk, mature B-cell non-Hodgkin's lymphoma a
179 ts efficacy and safety in children with high-grade, mature B-cell non-Hodgkin's lymphoma are limited.
180 Mdm2 oncogene, which is correlated with high-grade, metastatic tumors.
181 ed with earlier year of diagnosis and higher-grade tumors (P < 0.05).The overall pCR rate was 8.6%, i
182               The data indicates that higher-grade skin rejection does not occur in absence of mucosa
183  positive scans between patients with higher-grade and lower-grade primary tumors (Gleason score of >
184 ifferentiation between low- and intermediate-grade GEP NETs.
185                                          Low-grade dysplasia was a risk factor for progression but va
186                                          Low-grade inflammation was defined according to equally size
187                                          Low-grade inflammation, which is related to obesity and toxi
188                                          Low-grade lesions provided the greatest interpretative chall
189                                          Low-grade persistent inflammation is a feature of diabetes-d
190 umor CMRO(2), 0.23 mumol/g/min +/- 0.07; low-grade tumor CMRO(2), 0.39 mumol/g/min +/- 0.16; overall
191 ed (EL_INST: 17 patients, 17 lesions, 10 low-grade glioma, 3 cavernoma, 4 focal cortical dysplasia; N
192 l B-cell lymphoma (DLBCL/PMBCL; n = 28), low-grade B-cell lymphoma (n = 8), or chronic lymphocytic le
193 -three patients with cerebral gliomas (9 low-grade, 34 high-grade; 9 primary tumors, 34 recurrent tum
194 SMA-1007, however, may detect additional low-grade lesions of limited clinical relevance.
195 al features that are distinct from adult low-grade gliomas, and the developing paediatric brain is mo
196  Disturbances in glucose homeostasis and low-grade chronic inflammation culminate into metabolic synd
197 a from 335 adult patients with high- and low-grade glioma to form a replicable tumour frequency map.
198  expressed in human control subjects and low-grade HD patients.
199       In addition, OSAS is considered as low-grade systemic inflammation, which is associated with a
200  patients had a transient, asymptomatic, low-grade atrioventricular block that resolved spontaneously
201 icates a reciprocal relationship between low-grade systemic inflammation and stress exposure towards
202 logical types of childhood brain cancer: low-grade glioma (n = 93), ependymoma (32), high-grade gliom
203 o autoinflammatory diseases, which cause low-grade systemic inflammation and contribute to several co
204 encompasses genetic alterations, chronic low-grade inflammation and gut dysbiosis, has led to improve
205                  Obesity induces chronic low-grade inflammation in white adipose tissue (WAT).
206              OME is defined as a chronic low-grade inflammation of the middle ear (ME), without any s
207       Obesity is associated with chronic low-grade inflammation of visceral adipose tissue (AT) chara
208 stic of aging is the presence of chronic low-grade inflammation that is characterized by elevated con
209 lication of processes related to chronic low-grade inflammation, including a network involving methyl
210 ed in a personalized approach of chronic low-grade inflammation.
211 insight into the development of chronic, low-grade inflammation and oxidative stress in age-related d
212                                 Chronic, low-grade inflammation of VAT, and eventually systemically,
213            The development of a chronic, low-grade inflammation originating from adipose tissue in ob
214     Aging is characterized by a chronic, low-grade inflammation, which is a major risk factor for car
215      Metaflammation refers to a chronic, low-grade systemic inflammation as opposed to the classical
216                                 Chronic, low-grade, systemic, and mucosal inflammation correlates wit
217 cellular autoactivation and constitutive low-grade secretion of activated FXII.
218 s and quantify the burden of continuous, low-grade events.
219 normal follicle structures and developed low-grade serous ovarian carcinomas with 100% penetrance wit
220                We aimed to differentiate low-grade (Fuhrman I-II) from high-grade (Fuhrman III-IV) re
221                                  Diffuse low-grade gliomas (LGG) have been reclassified based on mole
222 s of Enterobacteriaceae that exacerbated low-grade mucosal inflammation, suggesting that remediating
223 LBCL/PMBCL, 63% (95% CI, 25% to 92%) for low-grade lymphoma, and 50% (95% CI, 16% to 84%) for CLL.
224 -years were 1.09 (95% CI, 0.85-1.33) for low-grade/high-grade dysplasia and 0.14 (95% CI, 0.06-0.22)
225                          Obesity fosters low-grade inflammation in white adipose tissue (WAT) that ma
226 further able to differentiate tumor from low-grade dysplasia.
227  melanocytic intraepithelial lesion from low-grade to high-grade in 2 (4%) of 47 cases.
228 ated within phase 3 trials of the German Low-Grade Lymphoma Study Group, were comparatively analyzed.
229 lation between the increased survival in low-grade glioma (LGG) and complementarity of IDH1 mutants t
230 and the use of Ras pathway inhibitors in low-grade gliomas.
231 augmenting the immune response to EBV in low-grade LYG include treatment with interferon-alpha2b, whe
232            Although the MEK Inhibitor in Low-Grade Serous Ovarian Cancer Study did not meet its prima
233 rimary and metastatic cancers, including low-grade and high-grade gliomas and brain metastases (BrMs)
234 llular and molecular processes including low-grade inflammation are major players in the pathogenesis
235 inib showed durable efficacy with mainly low-grade toxic effects in patients with medullary thyroid c
236 smural-ileitis on day 7, microscopically low-grade ileitis on day 22 and VH at days 7-22.
237 ract to govern Neurofibromatosis-1 (NF1) low-grade glioma (LGG) growth.
238 ase may have a recurrence in the form of low-grade disease after immunochemotherapy, and those with l
239 ly thereafter; and baseline diagnosis of low-grade dysplasia: at 1 and 3 years.
240                         The diagnoses of low-grade epilepsy associated neuroepithelial tumour (LEAT),
241                        Transformation of low-grade glioma into a higher tumor grade is typically asso
242 tudy presents a non-invasive analysis of low-grade gliomas using imaging features based on the update
243 nd TERT mutations) prediction methods of low-grade gliomas with imaging.
244 ty is associated with a chronic state of low-grade inflammation and progressive tissue infiltration b
245 e network system as neural correlates of low-grade inflammation and stress exposure, and suggest that
246  and HIF-1alpha activation as drivers of low-grade inflammation in obesity.
247                          Higher rates of low-grade screen-detected tumors were observed in the contro
248                 Primary chemoablation of low-grade upper tract urothelial cancer with intracavitary U
249                               Paediatric low-grade gliomas (also known as pLGG) are the most common t
250                   In general, paediatric low-grade gliomas show clinical and biological features that
251 ns for response assessment in paediatric low-grade gliomas.
252                                Pediatric low-grade gliomas (pLGG) are frequently driven by genetic al
253 ularly characterized cohort of pediatric low-grade gliomas (pLGGs) published to date.
254 une cell composition and likely promotes low-grade chronic inflammation, which has been proposed to b
255 with primary or recurrent biopsy-proven, low-grade upper tract urothelial cancer (measuring 5-15 mm i
256 roups were: low (non-metastatic R0 or R1 low-grade, or <=5 cm R1 high-grade tumour); intermediate (no
257 ion in patients diagnosed with high-risk low-grade gliomas.
258                        Evidence suggests low-grade inflammation as the cause of metabolic syndrome an
259   However, the implications of surviving low-grade ACLF in terms of risk of subsequent high-grade ACL
260  have hypothesized that chronic systemic low-grade inflammation may contribute to greater risk of dev
261  (hazard ratio [HR], 0.2; P < .001) than low-grade injuries.
262 on and stress exposure, and suggest that low-grade inflammation, alongside with stress, may render in
263 limited value in distinction between the low-grade and high-grade intraepithelial melanocytic prolife
264 assification correctly graded 76% of the low-grade cancers and 71% of the high-grade cancers accordin
265 ectivity among brain networks related to low-grade inflammation and stress exposure using two large i
266                                  Whereas low-grade levels of plasma cytokine/chemokine were apparent
267                                    While low-grade inflammation could impair immune response, it is u
268 ice-changing study for patients with WHO low-grade glioma (LGG, grade II), as it was the first to dem
269               Obesity is associated with low-grade chronic inflammation promoting insulin-resistance
270 after immunochemotherapy, and those with low-grade disease may progress to high-grade disease after i
271 etworks were reduced in association with low-grade inflammation and stress exposure.
272                           For those with low-grade SILs (LSILs) at baseline, the risk of progression
273                       Most patients with low-grade upper tract urothelial cancer are treated by radic
274 between patients with higher-grade and lower-grade primary tumors (Gleason score of >=4 + 3 vs. <3 +
275 re malignant brain tumors that include lower-grade gliomas (LGGs) and glioblastomas.
276 thods Data in patients with IDH-mutant lower-grade gliomas (World Health Organization grade II/III) a
277 godendroglioma is an important type of lower-grade glioma (LGG), which is a slowly progressing brain
278 0 patients from five institutions with lower-grade gliomas (World Health Organization grade II and II
279  in 2017 on ski runs, which had been machine-graded and hydroseeded in the 1990s.
280        The standard actions applied (machine-grading, storage and re-use of topsoil, hydroseeding of
281 perties and the long-term effects of machine-grading and subsequent restoration of ski runs so as to
282                                  The machine-grading of slopes involved during ski run construction c
283 vailability of hospital beds and key medical-grade equipment.
284 strongly corroborate the efficacy of medical-grade masks and highlight the importance of regular wash
285 ies while wearing different types of medical-grade or homemade masks.
286                                     Military-grade explosives such as 2,4,6-trinitroluene (TNT) are s
287 jury grade (adjusted odds ratio, 2.0 per one-grade increase [95% confidence interval {CI}: 1.6, 2.4];
288                    High-dose, pharmaceutical-grade biotin (MD1003) might enhance neuronal and oligode
289 trate that cells treated with pharmaceutical-grade rigosertib (>99.9% purity) or commercially obtaine
290 yne impurities for the production of polymer-grade lower olefins remains an important and challenging
291                                      Reagent-grade and affordable dietary supplement-grade ellagic ac
292                  Here, we report a reference-grade genome of T. wilfordii with a contig N50 of 4.36 M
293 , B, C, and AE), produced either as research-grade material in 293 and CHO cells or as two independen
294 utational and systems biology using research-grade technologies.
295 gent-grade and affordable dietary supplement-grade ellagic acid was sourced from tree bark and pomegr
296                     The ACDiT grading system-graded from 0 to 5b-is applied in this manner but has no
297 o overcome the global shortage of transplant-grade corneas.
298 e significantly associated with higher tumor-grade while 3/5 lncRNAs were also associated with no tum
299 ma-ray data and are able to identify weapons-grade plutonium, masked by naturally-occurring radioacti
300 e, a sphere of 4.5 kg of alpha-phase weapons-grade plutonium known as the BeRP ball, a 6 kg sphere of

 
Page Top